SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Preventive Visit — Arthur Ashe — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientArthur Ashe
Date of birth1943-07-10
IdentifiersMRN HR-ML013-SYN-TD; SSN (made up) 000-13-6620
Document date1989-08-17
AuthorVivian Tolliver, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit; no new concerns. [S]

History of Present Illness

Mr. Ashe is a 46-year-old man with HIV, diagnosed eleven months ago with cerebral toxoplasmosis and now well controlled on bictegravir, emtricitabine, and tenofovir alafenamide, and with coronary artery disease after two bypass operations, who comes for his yearly preventive visit five weeks after his six-month review. His viral load was not detected at three and six months, and his CD4 count was 262 last month. He takes every dose and knows to keep any antacid, calcium, or iron well apart from his HIV tablet; he has needed none. He has had no chest pain and has not needed nitroglycerin. He hits tennis balls three times a week and is back to full-time writing and coaching. His right hand has stayed strong. His weight has come back to where it was before his illness. Mood is good. He has told one more close friend about his diagnosis, on his own terms, and says that went well. He has no new concerns. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 46
HIVViral load not detected at three and six months; CD4 262 last month
HeartNo angina; no nitroglycerin use; exercising three times a week
MedicinesBictegravir, emtricitabine, and tenofovir alafenamide; trimethoprim-sulfamethoxazole; aspirin; atorvastatin; ezetimibe; nitroglycerin as needed, not used
Safety eventsNo emergency visits or hospital stays since discharge
DisclosureHis own choice; has told one more close friend

Health risk assessment. Completed by the patient on a tablet in a private room before the visit and reviewed with him by Dr. Tolliver; kept in the confidential part of the record. [S]

DomainFinding
Self-rated healthGood, and better than at any time since his diagnosis
PsychosocialSupported by his family and a few close friends; some worry about who might learn of his diagnosis; no loneliness
TobaccoNever used tobacco or e-cigarettes
Alcohol and drugsAUDIT-C 1; no other drug use
Physical activityTennis drills three times a week and daily walking; about 200 minutes a week
NutritionMediterranean-style diet; regular meals
SleepSeven hours a night
Sexual healthOne long-term partner; understands that an undetectable viral load means HIV is not transmitted sexually
Activities of daily livingIndependent
Home and road safetyWears a seat belt; smoke detectors working; no firearms in the home
Hearing and visionNo concerns
Oral healthNo dental visit in the past year

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight back to its usual level; no fever, night sweats, or fatigue
EyesNegativeNo floaters, blurred vision, or eye pain
Ears, nose, mouth, and throatNegativeNo mouth sores, white patches, or swallowing trouble
CardiovascularNegativeNo chest pain, palpitations, or ankle swelling
RespiratoryNegativeNo cough or breathlessness
GastrointestinalNegativeNo abdominal pain, diarrhea, or blood in the stool
GenitourinaryNegativeNo urinary symptoms, genital sores, or discharge
MusculoskeletalNegativeNo muscle aches on atorvastatin and ezetimibe; no joint pain
IntegumentaryNegativeNo rash or new skin lesions
NeurologicalNegativeNo headache, seizure, numbness, or weakness; right hand strong
PsychiatricNegativeMood good; PHQ-2 score 0; no thoughts of self-harm
Hematologic and lymphaticNegativeNo easy bruising or swollen glands

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg, one tablet by mouth once daily; take two hours before or six hours after antacids, calcium, iron, or magnesiumOne tablet by mouth once dailyOral route1988-09-25activeS
Pyrimethamine 25 mg oral tablet, 200 mg once, then three tablets (75 mg) by mouth daily for six weeks; course completed before intakeThree tablets by mouth daily after a 200 mg loading doseOral route1988-09-11 to 1988-10-23completedS
Sulfadiazine 500 mg oral tablet, three tablets (1500 mg) by mouth every 6 hours for six weeks; course completed before intakeThree tablets by mouth every 6 hoursOral route1988-09-11 to 1988-10-23completedS
Leucovorin 10 mg oral tablet, two tablets (20 mg) by mouth daily with pyrimethamine; course completed before intakeTwo tablets by mouth dailyOral route1988-09-11 to 1988-10-23completedS
Sulfamethoxazole 800 mg and trimethoprim 160 mg (double strength), one tablet by mouth twice dailyOne tablet by mouth twice dailyOral route1988-10-23 to 1989-10-19completedS
Aspirin 81 mg delayed-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1979-07-31activeS
Atorvastatin 80 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1979-08-01activeS
Ezetimibe 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1989-01-12activeS
Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tabletOne tablet under the tongue every 5 minutes as needed for chest pain, up to 3 dosesSublingual route1979-08-01activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1989-08-17Body height185cmS
1989-08-17Body weight74.8kgS
1989-08-17Body mass index (BMI) [Ratio]21.9kg/m2S
1989-08-17Systolic blood pressure118mm[Hg]S
1989-08-17Diastolic blood pressure72mm[Hg]S
1989-08-17Heart rate64/minS
1989-08-17Respiratory rate14/minS
1989-08-17Body temperature36.6CelS
1989-08-17Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1989-08-17Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1989-08-17Total score [AUDIT-C]1{score}S

Physical Exam

Vital signs recorded on 1989-08-17; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell and relaxed; weight 74.8 kg, BMI 21.9
EyesConjunctivae clear; pupils equal and reactive
MouthNo thrush, ulcers, or oral hairy leukoplakia; teeth and gums in fair repair
Neck and lymph nodesNo enlarged nodes in the neck, armpits, or groins
Chest wallHealed sternotomy scar
CardiovascularRegular rhythm at 64 per minute; no murmur; no edema
RespiratoryClear to auscultation bilaterally
AbdomenSoft and non-tender; no liver or spleen enlargement
SkinNo rash or suspicious lesions
NeurologicalGrip strength and fine finger movements equal on both sides; no focal deficit
PsychiatricEuthymic; good insight

Problems

ProblemClinical statusVerificationCodeProvenance
HIV infection, diagnosed about four months before intake with a CD4 count of 58 cells/uL and cerebral toxoplasmosis (an AIDS-defining illness); on antiretroviral therapy since; synthetic modern episode linked to the documented transfusion-acquired infectionactiveconfirmed B20S — Synthetic modern coding of the documented HIV infection and AIDS diagnosis; B20 stays the code after an AIDS-defining illness, however well the infection is controlled.
Cerebral toxoplasmosis, single left-sided lesion with right-hand weakness, diagnosed by stereotactic biopsy; six weeks of acute treatment completed; weakness recovered; on maintenance therapyactiveconfirmed B58.2S — Synthetic modern coding of the documented 1988 toxoplasmosis; the modern diagnosis was by biopsy rather than removal of the mass.
Coronary artery disease after two bypass operations (quadruple, then double), no angina; synthetic modern episode linked to the documented 1942 and 1946 operationsactiveconfirmed I25.10S — Synthetic modern diagnosis; the history remains D.
Old myocardial infarction at age 36activeconfirmed I25.2S — Synthetic coded history of the documented 1979 heart attack.
Hyperlipidemia, on high-intensity statinactiveconfirmed E78.5S — Synthetic diagnosis; no cholesterol value from his lifetime is used.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today118/72 mmHg
Cholesterol and statin therapyUp to dateSecondary prevention: LDL 52 mg/dL on atorvastatin 80 mg and ezetimibe; lipoprotein(a) 24 mg/dL; yearly lipid panel next due in the winter
Diabetes screeningUp to dateHbA1c 5.4 percent at intake; recheck yearly on antiretroviral therapy
Healthy weight and activityCompleted todayBMI 21.9; weight back to its level before his illness. Integrase inhibitors can cause weight gain, so weight is tracked at every visit
Colorectal cancer screeningOrderedRecommended from age 45; no prior screening. He chose colonoscopy, and a referral to gastroenterology was placed
Anal cancer screeningDueRecommended for people with HIV from age 45; the options (anal cytology with or without HPV testing, then high-resolution anoscopy if abnormal) were explained, and he will decide at the nine-month visit
Prostate cancer screeningNot indicatedShared decision-making about PSA testing begins at age 55
Lung cancer and abdominal aortic aneurysm screeningNot indicatedNever used tobacco
Depression screeningCompleted todayPHQ-2 score 0; PHQ-9 2 at the six-month review
Unhealthy alcohol use screeningCompleted todayAUDIT-C score 1
Syphilis screeningOrderedYearly for sexually active people with HIV; drawn today
Gonorrhea and chlamydia screeningNot indicatedOne long-term partner and no symptoms; review yearly
Hepatitis C screeningUp to dateAntibody negative at diagnosis; repeat only if a risk arises
Tuberculosis screeningUp to dateInterferon-gamma release assay negative at diagnosis
Recombinant zoster vaccineCompleted todayDose 2 given today, four months after dose 1; series complete
Hepatitis B vaccineUp to dateTwo-dose series complete; surface antibody 86 mIU/mL four months ago
Meningococcal ACWY vaccineUp to dateTwo-dose series complete; booster every five years
Pneumococcal vaccineUp to datePCV20 given at intake
Hepatitis A vaccineNot indicatedHepatitis A antibody positive at diagnosis; immune
Tetanus, diphtheria, and pertussis boosterUp to dateTdap five years ago; next booster in five years
Influenza and COVID-19 vaccines, this seasonDueBoth at the nine-month visit in the autumn
HPV vaccineNot indicatedNot recommended after age 45
Dental examinationDueNo dental visit in the past year; advised to book one, as recommended yearly for people with HIV

Immunizations given today: Recombinant zoster vaccine, dose 2 of 2 [S]

Guideline basis: Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America (2020); Adult Immunization Schedule by Medical Condition and Other Indication (2026); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026)

Follow-up: Nine-month HIV review in two months, with the influenza and COVID-19 vaccines and his decision about anal cancer screening. Colonoscopy through gastroenterology. Syphilis result by secure message. Next preventive visit in one year. Next scheduled visit 1989-10-19: nine-month HIV review: decision to stop toxoplasmosis maintenance therapy. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the confidential part of the chart and is not named here. He said that what matters most to him is staying active, his family, his work with young people, and keeping control of his own medical information. He chose not to record specific treatment preferences today. The plan will be revisited yearly or after any serious illness. [S]